Bristol-Myers Squibb Company (BMY) Revenue Growth
Bristol-Myers Squibb Company (BMY) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | -46.53% |
| 2018-12-31 | 8.59% |
| 2019-12-31 | 15.89% |
| 2020-12-31 | 62.62% |
| 2021-12-31 | 9.09% |
| 2022-12-31 | -0.49% |
| 2023-12-31 | -2.50% |
| 2024-12-31 | 7.32% |
| 2025-12-31 | -0.22% |
How BMY compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| BRKR | Bruker Corporation | 2.08% |
| MRK | Merck & Company Inc. | 1.31% |
| ALGN | Align Technology Inc. | 0.90% |
| AMPH | Amphastar Pharmaceuticals Inc. | -1.65% |
| HAE | Haemonetics Corporation | -1.97% |
These are five companies in the same sector as BMY with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Bristol-Myers Squibb Company Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("BMY", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | BMY | $67.66 | +1.11% | 7.82M |
| 3 | ||||
| 4 | ||||
| 5 |